EXELIXIS SELECTS SWEDISH ORPHAN BIOVITRUM

EXELIXIS SELECTS SWEDISH ORPHAN BIOVITRUM AB AS COMETRIQ (TM) EUROPEAN DISTRIBUTOR FOR MEDULLARY THYROID CANCER

Read more

EXELIXIS SELECTS SWEDISH ORPHAN BIOVITRUM

EXELIXIS SELECTS SWEDISH ORPHAN BIOVITRUM AB AS COMETRIQ (TM) EUROPEAN DISTRIBUTOR FOR MEDULLARY THYROID CANCER

Read more

Sobi gains distribution rights for Megace®, Monopril®, Cefzil® and Duricef® from PharmaSwiss

Sobi gains distribution rights for Megace®, Monopril®, Cefzil® and Duricef® from PharmaSwiss

Read more

Sobi gains distribution rights for Megace®, Monopril®, Cefzil® and Duricef® from PharmaSwiss

Sobi gains distribution rights for Megace®, Monopril®, Cefzil® and Duricef® from PharmaSwiss

Read more